Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884044665> ?p ?o ?g. }
- W2884044665 endingPage "58" @default.
- W2884044665 startingPage "53" @default.
- W2884044665 abstract "Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase (IDS), an enzyme that catabolizes glycosaminoglycans (GAGs) including heparan sulfate (HS) and dermatan sulfate (DS). GAG accumulation leads to severe neurological and somatic impairments. At present, the most common treatment for MPS II is intravenous enzyme replacement therapy; however, the inability of recombinant IDS to cross the blood-brain barrier (BBB) restricts therapeutic efficacy for neurological manifestations. We recently developed a BBB-penetrating IDS fusion protein, JR-141, and demonstrated its ability to reduce GAG accumulation in the brain of human transferrin receptor knock-in and Ids knock-out mice (TFRC-KI/Ids-KO), an animal model of MPS II, following intravenous administration. Given the impossibility of measuring GAG accumulation in the brains of human patients with MPS II, we hypothesized that GAG content in the cerebrospinal fluid (CSF) might serve as an indicator of brain GAG burden. To test this hypothesis, we optimized a high-sensitivity method for quantifying HS and DS in low-volume samples by combining acidic methanolysis and liquid chromatography-tandem mass spectrometry (LC/MS/MS). We employed this method to quantify HS and DS in samples from TFRC-KI/Ids-KO mice and revealed that HS but not DS accumulated in the central nerve system (CNS). Moreover, concentrations of HS in CSF correlated with those in brain. Finally, intravenous treatment with JR-141 reduced levels of HS in the CSF and brain in TFRC-KI/Ids-KO mice. These results suggest that CSF HS content may be a useful biomarker for evaluating the brain GAG accumulation and the therapeutic efficacy of drugs in patients with MPS II." @default.
- W2884044665 created "2018-08-03" @default.
- W2884044665 creator A5001359076 @default.
- W2884044665 creator A5023698512 @default.
- W2884044665 creator A5024703723 @default.
- W2884044665 creator A5035424097 @default.
- W2884044665 creator A5054073636 @default.
- W2884044665 creator A5056008744 @default.
- W2884044665 creator A5077538199 @default.
- W2884044665 date "2018-09-01" @default.
- W2884044665 modified "2023-10-11" @default.
- W2884044665 title "Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS" @default.
- W2884044665 cites W1481319330 @default.
- W2884044665 cites W1967749721 @default.
- W2884044665 cites W1971770267 @default.
- W2884044665 cites W1978346734 @default.
- W2884044665 cites W2001101692 @default.
- W2884044665 cites W2004893995 @default.
- W2884044665 cites W2010188647 @default.
- W2884044665 cites W2012973972 @default.
- W2884044665 cites W2034981978 @default.
- W2884044665 cites W2036630447 @default.
- W2884044665 cites W2043490832 @default.
- W2884044665 cites W2088174647 @default.
- W2884044665 cites W2092327321 @default.
- W2884044665 cites W2092848229 @default.
- W2884044665 cites W2102067858 @default.
- W2884044665 cites W2112373900 @default.
- W2884044665 cites W2135874839 @default.
- W2884044665 cites W2137730372 @default.
- W2884044665 cites W2138335140 @default.
- W2884044665 cites W2149155376 @default.
- W2884044665 cites W2307511944 @default.
- W2884044665 cites W2526629344 @default.
- W2884044665 cites W2745716847 @default.
- W2884044665 cites W2747229802 @default.
- W2884044665 cites W2793073482 @default.
- W2884044665 doi "https://doi.org/10.1016/j.ymgme.2018.07.013" @default.
- W2884044665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30064964" @default.
- W2884044665 hasPublicationYear "2018" @default.
- W2884044665 type Work @default.
- W2884044665 sameAs 2884044665 @default.
- W2884044665 citedByCount "31" @default.
- W2884044665 countsByYear W28840446652018 @default.
- W2884044665 countsByYear W28840446652019 @default.
- W2884044665 countsByYear W28840446652020 @default.
- W2884044665 countsByYear W28840446652021 @default.
- W2884044665 countsByYear W28840446652022 @default.
- W2884044665 countsByYear W28840446652023 @default.
- W2884044665 crossrefType "journal-article" @default.
- W2884044665 hasAuthorship W2884044665A5001359076 @default.
- W2884044665 hasAuthorship W2884044665A5023698512 @default.
- W2884044665 hasAuthorship W2884044665A5024703723 @default.
- W2884044665 hasAuthorship W2884044665A5035424097 @default.
- W2884044665 hasAuthorship W2884044665A5054073636 @default.
- W2884044665 hasAuthorship W2884044665A5056008744 @default.
- W2884044665 hasAuthorship W2884044665A5077538199 @default.
- W2884044665 hasBestOaLocation W28840446651 @default.
- W2884044665 hasConcept C104317684 @default.
- W2884044665 hasConcept C126322002 @default.
- W2884044665 hasConcept C153074725 @default.
- W2884044665 hasConcept C185592680 @default.
- W2884044665 hasConcept C2776225084 @default.
- W2884044665 hasConcept C2778041096 @default.
- W2884044665 hasConcept C2779134260 @default.
- W2884044665 hasConcept C2779416428 @default.
- W2884044665 hasConcept C2779651940 @default.
- W2884044665 hasConcept C2779969927 @default.
- W2884044665 hasConcept C2781197716 @default.
- W2884044665 hasConcept C2910638406 @default.
- W2884044665 hasConcept C2910727661 @default.
- W2884044665 hasConcept C40767141 @default.
- W2884044665 hasConcept C55493867 @default.
- W2884044665 hasConcept C71924100 @default.
- W2884044665 hasConceptScore W2884044665C104317684 @default.
- W2884044665 hasConceptScore W2884044665C126322002 @default.
- W2884044665 hasConceptScore W2884044665C153074725 @default.
- W2884044665 hasConceptScore W2884044665C185592680 @default.
- W2884044665 hasConceptScore W2884044665C2776225084 @default.
- W2884044665 hasConceptScore W2884044665C2778041096 @default.
- W2884044665 hasConceptScore W2884044665C2779134260 @default.
- W2884044665 hasConceptScore W2884044665C2779416428 @default.
- W2884044665 hasConceptScore W2884044665C2779651940 @default.
- W2884044665 hasConceptScore W2884044665C2779969927 @default.
- W2884044665 hasConceptScore W2884044665C2781197716 @default.
- W2884044665 hasConceptScore W2884044665C2910638406 @default.
- W2884044665 hasConceptScore W2884044665C2910727661 @default.
- W2884044665 hasConceptScore W2884044665C40767141 @default.
- W2884044665 hasConceptScore W2884044665C55493867 @default.
- W2884044665 hasConceptScore W2884044665C71924100 @default.
- W2884044665 hasFunder F4320310076 @default.
- W2884044665 hasIssue "1-2" @default.
- W2884044665 hasLocation W28840446651 @default.
- W2884044665 hasLocation W28840446652 @default.
- W2884044665 hasOpenAccess W2884044665 @default.
- W2884044665 hasPrimaryLocation W28840446651 @default.
- W2884044665 hasRelatedWork W1572142576 @default.
- W2884044665 hasRelatedWork W2045693782 @default.